CHICAGO – Sept. 16, 2021 – Andrew Tsui, of counsel in global law firm Greenberg Traurig, LLP’s Washington office, will speak at the 17th Annual Medical Device Coverage & Reimbursement Conference taking place Sept. 15-16, 2021.
Tsui will speak on Sept. 16 during part 1 of the conference's MCIT discussion titled "Deciphering CMS’ Medicare Coverage of Innovative Technologies Rule & Upcoming Impact on Device Reimbursement." The program will discuss topics including expediting access to reimbursed innovative medical devices, the impact of MCIT rule on the availability of cutting-edge technology, and alternative pathways for novel device coverage with or without MCIT adoption. Because the agency’s final rule was repealed on September 13, Tsui will discuss the current rulemaking underway, and next steps for industry.
Drawing on more than a decade of litigation experience with the U.S. Department of Health and Human Services (HHS) Office of the General Counsel for the Centers for Medicare & Medicaid Services (CMS) Division, Tsui assists health care clients seeking to develop comprehensive and durable approaches to the Medicare regulatory environment. His extensive background as lead agency counsel and his track record of success before both administrative and federal courts nationwide provides a unique optic to support the critical legal and business challenges his clients confront. A trusted advocate for healthcare providers and payers alike, Tsui also assists clients in the medical device, biopharmaceutical, and other emerging healthcare technology industries bring their products to market with confidence. His work with multi-national life sciences companies emphasizes the importance of developing a coverage, coding, and reimbursement approach that harmonizes with necessary FDA-approval processes.
Please register for this conference here.
About Greenberg Traurig’s Health Care & FDA Practice: Greenberg Traurig’s multidisciplinary Health Care & FDA Practice provides strategic counsel to a diverse group of companies and other organizations, helping them to responds proactively to the rapidly changing healthcare marketplace. The group combine dedicated experience in health care regulatory compliance and operational matters with the firm’s capabilities in corporate & securities, finance, tax, antitrust, ERISA, commercial and governmental litigation, restructuring, intellectual property and biotechnology, in order to provide a wide range of legal services.
About Greenberg Traurig: Greenberg Traurig, LLP (GT) has approximately 2300 attorneys in 40 locations in the United States, Latin America, Europe, Asia, and the Middle East. GT has been recognized for its philanthropic giving, diversity, and innovation, and is consistently among the largest firms in the U.S. on the Law360 400 and among the Top 20 on the Am Law Global 100. The firm is net carbon neutral with respect to its office energy usage and Mansfield Rule 4.0 Plus Certified. Web: www.gtlaw.com